pamidronate has been researched along with Carcinoma, Epidermoid in 13 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life." | 5.31 | [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer]. ( Hashitani, S; Matsushita, Y; Nishimura, N; Noguchi, K; Takaoka, K; Urade, M, 2002) |
| "Autopsy specimens of a bone metastasis from a woman with a primary squamous cell carcinoma of the tongue who developed multiple osteolytic lesions and hypercalcemia and was treated with pamidronate were studied histologically, histochemically, and ultrastructurally." | 3.69 | Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model. ( Hiraga, T; Nakajima, T; Ozawa, H; Takada, M, 1996) |
| "Hypercalcemia is a common complication of malignancy and portends a worse prognosis." | 1.40 | Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy. ( Pani, A; Reagan, P; Rosner, MH, 2014) |
| "Pamidronate was well tolerated and only grade 1 or 2 toxicities were registered." | 1.35 | Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis. ( Mitterer, M; Seeber, A; Spizzo, G, 2009) |
| "Although treatment of hypercalcemia with pamidronate is palliative, it is effective against the deterioration of quality of life." | 1.31 | [Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer]. ( Hashitani, S; Matsushita, Y; Nishimura, N; Noguchi, K; Takaoka, K; Urade, M, 2002) |
| "Hypercalcemia was defined as a serum Ca concentration higher than 11 mg/dl of the correction for serum albumin concentration." | 1.31 | Hypercalcemia in patients with oral squamous cell carcinoma. ( Iwase, M; Kakuta, S; Kurachi, Y; Nagumo, M; Nakamura-Mitsuhashi, M; Sakamaki, H, 2001) |
| "A 57-year-old man with lung squamous cell carcinoma revealed hypercalcemia, hypophosphoremia, elevation of nephrogenous cAMP and metabolic alkalosis." | 1.29 | A case of squamous cell lung carcinoma with high concentration of parathyroid hormone-related peptide in serum and pleural effusion presenting hypercalcemia. ( Haji, M; Hara, N; Ichinose, Y; Iguchi, H; Katakami, H; Nawata, H; Nishi, Y; Ohta, M; Tanaka, S, 1993) |
| "Malignant hypercalcemia is caused by both increased bone resorption and enhanced tubular reabsorption of calcium." | 1.28 | Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone. ( Burckhardt, P; Jaeger, P; Thiebaud, D, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (38.46) | 18.2507 |
| 2000's | 6 (46.15) | 29.6817 |
| 2010's | 2 (15.38) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arif, H | 1 |
| Beg, M | 1 |
| Zahid, S | 1 |
| Sial, M | 1 |
| Talwar, A | 1 |
| Christou, A | 1 |
| Babich, M | 1 |
| Reagan, P | 1 |
| Pani, A | 1 |
| Rosner, MH | 1 |
| Spizzo, G | 1 |
| Seeber, A | 1 |
| Mitterer, M | 1 |
| Nishimura, N | 1 |
| Matsushita, Y | 1 |
| Takaoka, K | 1 |
| Hashitani, S | 1 |
| Noguchi, K | 1 |
| Urade, M | 1 |
| Yoshiike, F | 1 |
| Koizumi, T | 1 |
| Yoneyama, A | 1 |
| Komatu, M | 1 |
| Yamaguchi, S | 1 |
| Hanaoka, M | 1 |
| Kubo, K | 1 |
| Eda, S | 1 |
| Ramadan, KM | 1 |
| McKenna, KE | 1 |
| Morris, TC | 1 |
| Mundy, GR | 1 |
| Iguchi, H | 2 |
| Katakami, H | 1 |
| Ichinose, Y | 1 |
| Nishi, Y | 1 |
| Tanaka, S | 1 |
| Hara, N | 1 |
| Ohta, M | 1 |
| Haji, M | 1 |
| Nawata, H | 1 |
| Hiraga, T | 1 |
| Takada, M | 1 |
| Nakajima, T | 1 |
| Ozawa, H | 1 |
| Endo, K | 1 |
| Katsumata, K | 1 |
| Kubodera, N | 1 |
| Teramoto, T | 1 |
| Ikeda, K | 1 |
| Fujita, T | 1 |
| Ogata, E | 1 |
| Bileckot, R | 1 |
| Touazi, S | 1 |
| Auvinet, B | 1 |
| Le Lain, JC | 1 |
| Iwase, M | 1 |
| Kurachi, Y | 1 |
| Kakuta, S | 1 |
| Sakamaki, H | 1 |
| Nakamura-Mitsuhashi, M | 1 |
| Nagumo, M | 1 |
| Thiebaud, D | 1 |
| Jaeger, P | 1 |
| Burckhardt, P | 1 |
1 review available for pamidronate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Refractory Hypercalcemia in Squamous Cell Carcinoma of the Esophagus-a Case Report and Review of Literature.
Topics: Calcitonin; Calcium; Calcium-Regulating Hormones and Agents; Carcinoma, Squamous Cell; Cinacalcet; D | 2019 |
12 other studies available for pamidronate and Carcinoma, Epidermoid
| Article | Year |
|---|---|
Approach to diagnosis and treatment of hypercalcemia in a patient with malignancy.
Topics: Aged; Antineoplastic Agents; Bone and Bones; Bone Density Conservation Agents; Carcinoma, Squamous C | 2014 |
Routine use of pamidronate in NSCLC patients with bone metastasis: results from a retrospective analysis.
Topics: Adenocarcinoma; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Bone Neoplasms; Carcinoma, Ad | 2009 |
[Treatment of hypercalcemia of malignancy with pamidronate in a patient with advanced recurrent oral cancer].
Topics: Adult; Antineoplastic Agents; Carcinoma, Squamous Cell; Consciousness Disorders; Diphosphonates; Dru | 2002 |
Thymic squamous cell carcinoma producing parathyroid hormone-related protein and CYFRA 21-1.
Topics: Antigens, Neoplasm; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biopsy; C | 2004 |
Clinical response of cutaneous squamous-cell carcinoma to bortezomib given for myeloma.
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bor | 2006 |
Evaluation and treatment of hypercalcemia.
Topics: Adenoma; Aged; Bone Neoplasms; Carcinoma, Squamous Cell; Diagnosis, Differential; Diphosphonates; Fe | 1994 |
A case of squamous cell lung carcinoma with high concentration of parathyroid hormone-related peptide in serum and pleural effusion presenting hypercalcemia.
Topics: Blotting, Northern; Carcinoma, Squamous Cell; Chromatography, Gel; Diagnosis, Differential; Diphosph | 1993 |
Effects of bisphosphonate (pamidronate) on bone resorption resulting from metastasis of a squamous cell carcinoma: report of an autopsy case and evaluation of bone resorbing activity in an experimental animal model.
Topics: Acid Phosphatase; Aged; Animals; Bone Neoplasms; Bone Resorption; Carcinoma, Squamous Cell; Diphosph | 1996 |
Effect of combination treatment with a vitamin D analog (OCT) and a bisphosphonate (AHPrBP) in a nude mouse model of cancer-associated hypercalcemia.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cachexia; Calcitriol | 1998 |
[Analgesic effect of Pamidronate on bone pain in patient with hypertrophic pulmonary osteoarthropathy].
Topics: Anti-Inflammatory Agents; Antineoplastic Agents; Carcinoma, Squamous Cell; Diphosphonates; Drug Admi | 2001 |
Hypercalcemia in patients with oral squamous cell carcinoma.
Topics: Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Calcitonin; Carcinoma, Squamous Cell; Diphosphona | 2001 |
Response to retreatment of malignant hypercalcemia with the bisphosphonate AHPrBP (APD): respective role of kidney and bone.
Topics: Bone and Bones; Breast Neoplasms; Calcium; Carcinoma, Squamous Cell; Diphosphonates; Female; Humans; | 1990 |